Skip to main content
All lobbying filings

FORWARD GLOBAL

Lobbying for QUOIN PHARMACEUTICALS, INC. · Development and commercialization of therapeutic drug products that treat rare diseases.

 Filing 1st Quarter - Report
1st Quarter (Jan 1 - Mar 31) 2026 · Virginia · House · Senate · $20,000.00 income · posted Apr 20, 2026

Official filing document

 Lobbying activity 3
Health Issues

Lobbying for continued funding from the government for rare disease research and development, including through the Rare Pediatric Disease Designation and Priority Review Voucher Programs; advocating for greater awareness about the rare disease community for doctors via the Give Kids a Chance Act.

Medical/Disease Research/Clinical Labs

Lobbying for continued funding from the government for rare disease research and development, including through the Rare Pediatric Disease Designation and Priority Review Voucher Programs; advocating for greater awareness about the rare disease community for doctors via the Give Kids a Chance Act.

Pharmacy

Lobbying for continued funding from the government for rare disease research and development, including through the Rare Pediatric Disease Designation and Priority Review Voucher Programs; advocating for greater awareness about the rare disease community for doctors via the Give Kids a Chance Act.

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.

Report a problem